The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Concept OB
Vitamin Mineral Supplement · FERROUS FUMARATE 42.5 mg/1; IRON 42.5 mg/1; ASCORBIC ACID 210 mg/1; FOLIC ACID 1 mg/1; THIAMINE MONONITRATE 5 mg/1; RIBOFLAVIN 5 mg/1; NIACIN 20 mg/1; CALCIUM PANTOTHENATE 7 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; BIOTIN 300 ug/1; CYANOCOBALAMIN 10 ug/1; CUPRIC SULFATE 800 ug/1; MAGNESIUM SULFATE, UNSPECIFIED FORM 6.9 mg/1; MANGANESE SULFATE 1.3 mg/1; ZINC SULFATE, UNSPECIFIED FORM 18.2 mg/1 · Capsule · Oral · U.S. Pharmaceutical Corporation
NDC 52747-0620-10 · 10 BLISTER PACK in 1 BOX / 4 CAPSULE in 1 BLISTER PACK · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Vitamin Mineral Supplement (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| U.S. Pharmaceutical Corporation | FERROUS FUMARATE 42.5 mg/1; IRON 42.5 mg/1; ASCORBIC ACID 210 mg/1; FOLIC ACID 1 mg/1; THIAMINE MONONITRATE 5 mg/1; RIBOFLAVIN 5 mg/1; NIACIN 20 mg/1; CALCIUM PANTOTHENATE 7 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; BIOTIN 300 ug/1; CYANOCOBALAMIN 10 ug/1; CUPRIC SULFATE 800 ug/1; MAGNESIUM SULFATE, UNSPECIFIED FORM 6.9 mg/1; MANGANESE SULFATE 1.3 mg/1; ZINC SULFATE, UNSPECIFIED FORM 18.2 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| U.S. Pharmaceutical Corporation | FERROUS FUMARATE 210 mg/1; IRON 300 ug/1; ASCORBIC ACID 7 mg/1; FOLIC ACID 800 ug/1; THIAMINE MONONITRATE 10 ug/1; RIBOFLAVIN 42.5 mg/1; NIACIN 1 mg/1; CALCIUM PANTOTHENATE 42.5 mg/1; PYRIDOXINE HYDROCHLORIDE 6.9 mg/1; BIOTIN 1.3 mg/1; CYANOCOBALAMIN 20 mg/1; CUPRIC SULFATE 25 mg/1; MAGNESIUM SULFATE, UNSPECIFIED FORM 5 mg/1; MANGANESE SULFATE 5 mg/1; ZINC SULFATE, UNSPECIFIED FORM 18.2 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| U.S. Pharmaceutical Corporation | ASCORBIC ACID 210 mg/1; BIOTIN 300 ug/1; CALCIUM PANTOTHENATE 7 mg/1; CUPRIC SULFATE 800 ug/1; CYANOCOBALAMIN 10 ug/1; FERROUS FUMARATE 42.5 mg/1; FOLIC ACID 1 mg/1; IRON 42.5 mg/1; MAGNESIUM SULFATE, UNSPECIFIED FORM 6.9 mg/1; MANGANESE SULFATE 1.3 mg/1; NIACIN 20 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; RIBOFLAVIN 5 mg/1; THIAMINE MONONITRATE 5 mg/1; ZINC SULFATE, UNSPECIFIED FORM 18.2 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Concept OB — NDC 52747-0620-10," retrieved September 3, 2026, https://drugdashboards.com/drug/52747062010.
Free to cite with attribution — see how the data is put together.